Article
Updates on CRISPR-based gene editing in HIV-1/AIDS therapy
19 Jan 2022
Abstract excerpt
Although tremendous efforts have been made to prevent and treat HIV-1 infection, HIV-1/AIDS remains a major threat to global human health. The combination antiretroviral therapy (cART), although able to suppress HIV-1 replication, cannot eliminate the proviral DNA integrated into the human genome and thus requires lifelong treatment that may lead to various side effects. In recent years, clustered regularly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
